go back

Kentucky rates for HCPCS M0244

Intravenous infusion or subcutaneous injection, casirivimab and imdevimab, includes infusion or injection and post administration monitoring in the home or residence; this includes a beneficiary's home that has been made provider-based to the hospital during the COVID-19 public health emergency

Insurance Carrier
CareSource
Facility/Professional
Facility
Modifier
Low / Median / High Price
$1,470.37 / $48,999.51 / $62,999.37
CareSource
Facility/Professional
Professional
Modifier
Low / Median / High Price
$742.61 / $1,098.01 / $1,470.37